Egetis Therapeutics AB (publ) (EGTX) — Tangible Net Worth Ratio
Egetis Therapeutics AB (publ) (EGTX) has a Tangible Net Worth Ratio of -11.0% as of June 2025. This metric is calculated by deducting intangible assets (Skr394.00 Million) from net assets (Skr355.10 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See EGTX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Egetis Therapeutics AB (publ) Tangible Net Worth Ratio (2008–2024)
This chart shows how Egetis Therapeutics AB (publ)'s Tangible Net Worth Ratio has changed across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at -11.0%, reflecting net assets of Skr355.10 Million with intangible assets of Skr394.00 Million SEK. See how many days can Egetis Therapeutics AB (publ) fund operations to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Egetis Therapeutics AB (publ) (2008–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Egetis Therapeutics AB (publ) from 2008 to 2024, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Egetis Therapeutics AB (publ) market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 17.2% | Skr492.90 Million | Skr408.00 Million | Skr792.30 Million | ▼ -7.8 pp |
| 2023 | 25.0% | Skr545.60 Million | Skr409.10 Million | Skr760.20 Million | ▲ +6.1 pp |
| 2022 | 18.9% | Skr506.20 Million | Skr410.30 Million | Skr561.10 Million | ▼ -3.0 pp |
| 2021 | 22.0% | Skr527.04 Million | Skr411.31 Million | Skr569.27 Million | ▲ +15.6 pp |
| 2020 | 6.4% | Skr629.63 Million | Skr589.36 Million | Skr893.97 Million | ▼ -93.6 pp |
| 2019 | 100.0% | Skr244.88 Million | Skr0.00 | Skr270.07 Million | ▲ +0.0 pp |
| 2018 | 100.0% | Skr219.36 Million | Skr0.00 | Skr242.04 Million | ▲ +0.0 pp |
| 2017 | 100.0% | Skr303.71 Million | Skr0.00 | Skr315.37 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Skr389.56 Million | Skr0.00 | Skr396.44 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Skr48.03 Million | Skr0.00 | Skr52.36 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Skr90.66 Million | Skr0.00 | Skr103.47 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr46.95 Million | Skr0.00 | Skr51.01 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr53.94 Million | Skr0.00 | Skr60.46 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Skr87.53 Million | Skr0.00 | Skr91.42 Million | ▲ +110.0 pp |
| 2010 | -10.0% | Skr6.99 Million | Skr7.69 Million | Skr8.49 Million | ▼ -108.6 pp |
| 2009 | 98.6% | Skr5.64 Million | Skr79.46K | Skr5.91 Million | ▼ -1.4 pp |
| 2008 | 100.0% | Skr5.05 Million | Skr0.00 | Skr5.37 Million | — |